DrugPatentWatch Database Preview

DIHYDROERGOTAMINE MESYLATE Drug Profile

« Back to Dashboard

Which patents cover Dihydroergotamine Mesylate, and what generic alternatives are available?

Dihydroergotamine Mesylate is a drug marketed by Hikma Pharms, Paddock Llc, Sagent Pharms Inc, and West-ward Pharms Int. and is included in four NDAs.

The generic ingredient in DIHYDROERGOTAMINE MESYLATE is dihydroergotamine mesylate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.

Summary for DIHYDROERGOTAMINE MESYLATE

US Patents:	0
Applicants:	4
NDAs:	4
Suppliers / Packagers:	4
Bulk Api Vendors:	58
Clinical Trials:	12
Patent Applications:	657
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for DIHYDROERGOTAMINE MESYLATE
DailyMed Link:	DIHYDROERGOTAMINE MESYLATE at DailyMed

See drug prices for DIHYDROERGOTAMINE MESYLATE

Recent Clinical Trials for DIHYDROERGOTAMINE MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Satsuma Pharmaceuticals, Inc.	Phase 3
Satsuma Pharmaceuticals, Inc.	Phase 1
Impel NeuroPharma Inc.	Phase 1

See all DIHYDROERGOTAMINE MESYLATE clinical trials

Pharmacology for DIHYDROERGOTAMINE MESYLATE

Drug Class

Ergotamine Derivative

Medical Subject Heading (MeSH) Categories for DIHYDROERGOTAMINE MESYLATE

Analgesics, Non-Narcotic

Dopamine Agonists

Vasoconstrictor Agents

Synonyms for DIHYDROERGOTAMINE MESYLATE

(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman mesylate

(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman methanesulfonate

(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxa

(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide

(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate

(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate

11032-41-0

511-12-6 (Parent)

6190-39-2

81AXN7R2QT

9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione mesylate

9,10-Dihydroergotamine mesylate

9,10-dihydroergotamine methanesulfonate

910882-41-6

AC1L2FO7

AC1LAOVT

AC1Q6WD6

ADYPXRFPBQGGAH-UMYZUSPBSA-N

AKOS024282478

AN-21195

ANW-42737

C33H37N5O5.CH4O3S

CCG-39548

CHEBI:59756

CHEMBL1200517

CHEMBL1396675

CS-2903

CTK8B3562

D 2763

D.H.E. 45

D02211

D2633

DETMS

DHE-45

Dihydergot

Dihydroergotamine (mesylate)

Dihydroergotamine for peak identification, European Pharmacopoeia (EP) Reference Standard

Dihydroergotamine mesilate

Dihydroergotamine mesilate (JP17)

Dihydroergotamine mesilate, European Pharmacopoeia (EP) Reference Standard

Dihydroergotamine mesylate (USP)

Dihydroergotamine mesylate [USAN:USP]

Dihydroergotamine mesylate [USAN]

Dihydroergotamine mesylate, United States Pharmacopeia (USP) Reference Standard

Dihydroergotamine methanesulfonate

Dihydroergotamine methanesulfonate salt

Dihydroergotamine methanesulfonate salt, powder

Dihydroergotamine monomethanesulfonate

Dihytamine

EINECS 228-235-6

Ergotamine, 9,10-dihydro-, monomethanesulfonate (salt)

Ergotamine, dihydro, methanesulfonate (salt)

Ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, monomethanesulfonate (salt)

EU-0100357

HMS1920G16

HMS2094K05

HMS2231H03

HMS3261G15

HMS3266C22

HMS3369K10

HMS501N14

HY-B0670A

I14-101170

LP00357

LS-64558

MFCD00058615

mide methanesulfonate

MLS002153175

MLS002207048

MolPort-003-666-163

MT 300

NCGC00261042-01

NSC-759848

NSC759848

Pharmakon1600-01500248

Prestwick_746

rboxamide methanesulfonate(salt)

SCHEMBL40843

SCHEMBL40844

SMR001230668

SPECTRUM1500248

SR-01000075382

SR-01000075382-1

SR-01000075382-3

SR-01000597746

SR-01000597746-1

ST056346

Tox21_500357

TR-021291

TRA0034972

UNII-81AXN7R2QT

Z1544404034

US Patents and Regulatory Information for DIHYDROERGOTAMINE MESYLATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Pharms	DIHYDROERGOTAMINE MESYLATE	dihydroergotamine mesylate	INJECTABLE;INJECTION	206621-001	Sep 15, 2017	AP	RX	No	No
West-ward Pharms Int	DIHYDROERGOTAMINE MESYLATE	dihydroergotamine mesylate	INJECTABLE;INJECTION	040453-001	Jun 9, 2003	AP	RX	No	No
Paddock Llc	DIHYDROERGOTAMINE MESYLATE	dihydroergotamine mesylate	INJECTABLE;INJECTION	040475-001	Apr 28, 2003	AP	RX	No	No
Sagent Pharms Inc	DIHYDROERGOTAMINE MESYLATE	dihydroergotamine mesylate	INJECTABLE;INJECTION	207264-001	Jul 11, 2018	AP	RX	No	No